360 related articles for article (PubMed ID: 17908999)
1. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
[TBL] [Abstract][Full Text] [Related]
2. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression.
Shah K; Bureau E; Kim DE; Yang K; Tang Y; Weissleder R; Breakefield XO
Ann Neurol; 2005 Jan; 57(1):34-41. PubMed ID: 15622535
[TBL] [Abstract][Full Text] [Related]
3. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
4. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
6. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand.
Ehtesham M; Kabos P; Gutierrez MA; Chung NH; Griffith TS; Black KL; Yu JS
Cancer Res; 2002 Dec; 62(24):7170-4. PubMed ID: 12499252
[TBL] [Abstract][Full Text] [Related]
7. A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models.
Bagci-Onder T; Wakimoto H; Anderegg M; Cameron C; Shah K
Cancer Res; 2011 Jan; 71(1):154-63. PubMed ID: 21084267
[TBL] [Abstract][Full Text] [Related]
8. Radioresponsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors.
Tsurushima H; Yuan X; Dillehay LE; Leong KW
Cancer Gene Ther; 2007 Aug; 14(8):706-16. PubMed ID: 17541421
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Chan JA; Krichevsky AM; Kosik KS
Cancer Res; 2005 Jul; 65(14):6029-33. PubMed ID: 16024602
[TBL] [Abstract][Full Text] [Related]
10. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.
Xia H; Qi Y; Ng SS; Chen X; Li D; Chen S; Ge R; Jiang S; Li G; Chen Y; He ML; Kung HF; Lai L; Lin MC
Brain Res; 2009 May; 1269():158-65. PubMed ID: 19265686
[TBL] [Abstract][Full Text] [Related]
11. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo.
Shah K; Tang Y; Breakefield X; Weissleder R
Oncogene; 2003 Oct; 22(44):6865-72. PubMed ID: 14534533
[TBL] [Abstract][Full Text] [Related]
12. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
[TBL] [Abstract][Full Text] [Related]
13. Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.
Pisati F; Belicchi M; Acerbi F; Marchesi C; Giussani C; Gavina M; Javerzat S; Hagedorn M; Carrabba G; Lucini V; Gaini SM; Bresolin N; Bello L; Bikfalvi A; Torrente Y
Cancer Res; 2007 Apr; 67(7):3054-63. PubMed ID: 17409412
[TBL] [Abstract][Full Text] [Related]
14. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
Wang WB; Zhou YL; Heng DF; Miao CH; Cao YL
Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis.
Shah K; Tung CH; Breakefield XO; Weissleder R
Mol Ther; 2005 Jun; 11(6):926-31. PubMed ID: 15922963
[TBL] [Abstract][Full Text] [Related]
16. [The mechanism of apoptosis in human U87 glioma cells induced by miR-21 antisense oligonucleotide].
Shi L; Cheng Z; Zhang J; Li R; You Y; Fu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):497-501. PubMed ID: 18841558
[TBL] [Abstract][Full Text] [Related]
17. Radio-responsive TRAIL gene therapy for malignant gliomas.
Kyritsis AP; Rao JS; Puduvalli VK
Cancer Gene Ther; 2007 Dec; 14(12):1002. PubMed ID: 17704752
[No Abstract] [Full Text] [Related]
18. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.
Fu W; Chu L; Han X; Liu X; Ren D
J Gene Med; 2008 Jun; 10(6):690-701. PubMed ID: 18338832
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.
Tagscherer KE; Fassl A; Campos B; Farhadi M; Kraemer A; Böck BC; Macher-Goeppinger S; Radlwimmer B; Wiestler OD; Herold-Mende C; Roth W
Oncogene; 2008 Nov; 27(52):6646-56. PubMed ID: 18663354
[TBL] [Abstract][Full Text] [Related]
20. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo.
de Groot JF; Liu TJ; Fuller G; Yung WK
Cancer Res; 2005 Mar; 65(5):1934-40. PubMed ID: 15753393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
